Constipation Amitiza

By | October 10, 2014

Amitiza (lubiprostone) is indicated for the treatment of chronic idiopathic constipation, and opioid induced constipation in chronic non-cancer pain in adults, and irritable bowel syndrome with constipation in women aged 18 years and older.

Fallon Community Health Plan Department of Pharmacy Services Page 1 of 2 Prior Authorization Approval Criteria Amitiza (lubiprostone) Generic name: Lubiprostone

Lubiprostone (Amitiza) for opioid-induced constipation in patients with chronic non-cancer pain Author: NIHR Horizon Scanning Centre Keywords: Lubiprostone; Amitiza; Opioid-induced constipation; Non-cancer pain Created Date:

Have constipation or a related condition called irritable bowel syn-drome. A variety of treatments are available over-the-counter and by Amitiza is also approved for women who have IBS with con-stipation as the main symptom (and many doctors will pre-scribe it for men, too).

These medications locally target intestinal chloride channels to help regulate fluid balance. Chronic idiopathic constipation is generally defined as

2014 AMITIZA PRIOR AUTHORIZATION FORM- Coverage Criteria: Diagnosis for use: For the treatment of irritable bowel syndrome with constipation (IBS-C)

Constipation is considered to be chronic if it has affected you for a long time. Lubiprostone (also known as Amitiza) is a drug that works by increasing the amount of fluid in the intestine. This helps stools to move through the intestine,

Rev 12/2012 CClliinniiccaall IINNSSIIGGHHTT AAnnaallyyssiiss Issue 3 June 2010 Amitiza® (lubiprostone) Oral Treatment for Constipation Ind iccaattioonn:: Amitiza® is indicated for treatment of chronic idiopathic constipation (CIC) in adults

constipation? Y N the answer to this question is no, then no further questions required.][If 6. Has the patient had less than 3 spontaneous bowel movements per week, on average, for at least 6 months with any of the Amitiza prior authorization form

Lubiprostone (Amitiza) for chronic idiopathic constipation . SUMMARY NIHR HSC ID: 2818 . Lubiprostone is intended to be used for the treatment of chronic idiopathic constipation (CIC). If licensed, lubiprostone will provide an additional

Amitiza® (Lubiprostone) FDA-APPROVED INDICATION Amitiza is indicated for: A. The treatment of chronic idiopathic constipation in the adult population. B. The treatment of Irritable Bowel Syndrome with constipation in the adult population.

PRECAUTIONS Patient Information: AMITIZA™ may cause nausea. If this occurs, concomitant administration of food with AMITIZA ™ may reduce symptomsof

AMITIZA (lubiprostone) PRIOR AUTHORIZATION FORM Coverage Policy: Covered for treatment of adult patients with chronic idiopathic constipation, and adult female patients with Irritable Bowel Syndrome with Constipation who are over 18 years of age, and have tried and failed generic Miralax

6064 FLAMIT 0313 PRIME THERAPEUTICS LLC 03/13 AMITIZA & LINZESSTM PREAUTHORIZATION REQUEST PHYSICIAN FAX FORM Only the prescriber may complete this form.

Bowel syndrome with constipation Mahmoud Soubra and Ron Schey Division of Gastroenterology and Hepatology, (Amitiza) was approved by the US Food and Drug Administration (FDA) for the treatment of women with IBS-C. It is thought to selectively activate

PRIOR AUTHORIZATION QUESTIONNAIRE – AMITIZA For the diagnosis of opioid-induced constipation, does the patient have chronic, non-cancer pain? Yes No 7. Has the patient tried and failed a PEG 3350-based product (Miralax, Glycolax)?

These medications locally target intestinal chloride channels to help regulate fluid balance. Chronic idiopathic constipation is generally defined as

CAREMARK FAX FORM . Amitiza . This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax signed forms to CVS constipation (constipation for more than 6 months not due to any .